a method of synthesizing a compound in which one enantiomer is produced in greater amounts than the other
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
(R)-3-METHYL-1-PHENYLBUTAN-1-AMINE-HCl
(2S,4R)-2-ethoxycarbonyl-1-(toluene-4-sulfonyl)-4-(toluene-4-sulfonyloxy)pyrrolidine
dibenzyl (E)-1-propenylphosphonate
C28H50O4Si2
(2S,3S)-2-(1-methylethyl)-4-nitro-3-phenylbutyraldehyde
N-benzyloxycarbonyl-(E)-4-(2-aminophenyl)-1-phenylbut-2-en-1-one
ethyl 3E-<(1R,2S)-2-phenyl-1-cyclopropyl>prop-1-enoate
methyl phaseate
fumagillol
(R)-3-((E)-Hept-1-enyl)-4-phenyl-oxazolidin-2-one
(5aS)-7β,9aβ-Dimethyl-6-methylene-4,5,5aα,6,7,8,9,9a-octahydronaphtho[1,2-c]furan-1(3H)-one
(S)-2,4-dibenzyl-5-oxo-2,5-dihydrofuran-3-yl (2S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate
3’-isopropyl-4’,5’-dimethoxyacetophenone
(S)-methyl 2-phenyl-2-(piperdin-1-yl)propanoate
(3-dimethylaminopropyl)diphenoxyphenylstannane
)
C19H21NO3
(2Z,4E)-5-(1-Hydroxy-2-hydroxymethyl-6,6-dimethyl-4-oxo-cyclohex-2-enyl)-3-methyl-penta-2,4-dienoic acid methyl ester
(1R,2'S)-(-)-N-[2'-(3,4-dimethoxyphenyl)propyl]-2-methoxy-1-phenylethylamine
1,3-Pentanediol, 5-(5-methyl-2-furanyl)-, 1-benzoate, (S)-
(S)-(-)-2-amino-1-cyano-5-methyl-5-phenyl-1,3-cyclopentadiene
(3R,αS,E)-tert-butyl 3-(N-benzyl-N-α-methylbenzylamino)-3-[4-(3-tert-butoxy-3-oxoprop-1-enyl)phenyl]propanoate
(1R,3R,3aR,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-4-((phenylthio)methyl)dodecahydronaphtho[2,3-c]furan
(4R,5S)-3-((Z)-Dec-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one
(R)-2-benzyloxy-2-methylmalonic acid monoethyl ester
(3S,4S)-2-[4-isopropenyl-1-(toluene-4-sulfonyl)-pyrrolidin-3-yl]ethanol
(4S,5S)-2-<(S)-1-(N,N-dimethylhydrazino)ethyl>-1,3-dimethyl-4,5-diphenylimidazolidine
(2S,3R)-3-fluoro-1-<(4-methylphenyl)sulfenyl>-5-hexen-2-ol
(1'R,2R,4R)-2-methyl-4-phenyl-N-(1'-phenylethyl)oxazolidine
Benzenemethanol, 2,3,4,5,6-pentafluoro-a-(phenylethynyl)-
(+)-(1S,2S,3S)-2,3-bis<(benzyloxy)methyl>-1-cyclobutyl acetate
ethyl 4-(3-oxoprop-1-yn-1-yl)benzoate
[(S)-3-(3,4-Dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-yl]-methanol
N-ForMyl-
(R*,R*)-β-<(2-carboxyethyl)thio>-α-methoxy-2-(8-phenyloctyl)benzenepropanoic acid
(1S,2R)-2-allyl-1-(3,4-methylenedioxyphenyl)-1,3-propanediol
(Z)-2-Methyl-4-triisopropylsilanyloxy-but-2-enoic acid (2-iodo-phenyl)-methyl-amide
[2-((1R,3aS,4S,7aR)-6-Methoxy-4-methyl-hexahydro-furo[3,4-c]pyran-1-ylethynyl)-phenyl]-carbamic acid ethyl ester
C35H48OSi
(4R,S(S))-N-(tert-butylsulfinyl)-4-phenylbut-1-en-4-amine
(3bS,9bS)-6-hydroxy-7-isopropyl-9b-methyl-3b,4,10,11-tetrahydrophenanthro[1,2-c]furan-1,5(3H,9bH)-dione
1-Pyrrolidinecarboxylic acid, 2-(trimethylsilyl)-, 1,1-dimethylethyl ester, (2R)-
C31H42O5Si
(S)-4-Methyl-1-((R)-toluene-4-sulfinyl)-pent-3-en-2-ol
(S)-2-(ethylthio)-4-[(S)-1-(2-fluorophenyl)-2-nitroethyl]-4-isopropylthiazol-5(4H)-one
2-Propenoic acid, 2-(benzoylamino)-3-(2-thienyl)-, methyl ester, (2Z)-
